BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heublein S, Friese K, Kost B, Marmé F, Kuhn C, Mahner S, Dannecker C, Mayr D, Jeschke U, Vattai A. TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer. J Cancer Res Clin Oncol 2018;144:1899-907. [PMID: 30062487 DOI: 10.1007/s00432-018-2706-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Houvast RD, Vankemmelbeke M, Durrant LG, Wuhrer M, Baart VM, Kuppen PJK, de Geus-Oei LF, Vahrmeijer AL, Sier CFM. Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging. Cancers (Basel) 2020;12:E3870. [PMID: 33371487 DOI: 10.3390/cancers12123870] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]